Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Awaiting price reaction for this filing.
Eris Lifesciences has submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 31 March 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India). It confirms that all physical share certificates received for dematerialization during the quarter were processed, confirmed or rejected by the depositories, and mutilated certificates were cancelled with the depositories' names substituted as registered owners within the prescribed timelines. The filing was signed by Milind Talegaonkar, Company Secretary, and is addressed to BSE, NSE, NSDL, and CDSL.
This is a standard quarterly procedural filing with no impact on business operations, financials, or shareholder value. It simply confirms that the company's share transfer processes are functioning in compliance with SEBI norms.